Sara Lucidi

641 total citations · 1 hit paper
15 papers, 352 citations indexed

About

Sara Lucidi is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Sara Lucidi has authored 15 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Sara Lucidi's work include Prostate Cancer Treatment and Research (4 papers), Glioma Diagnosis and Treatment (3 papers) and Breast Cancer Treatment Studies (3 papers). Sara Lucidi is often cited by papers focused on Prostate Cancer Treatment and Research (4 papers), Glioma Diagnosis and Treatment (3 papers) and Breast Cancer Treatment Studies (3 papers). Sara Lucidi collaborates with scholars based in Italy. Sara Lucidi's co-authors include Lorenzo Livi, Isacco Desideri, Daniela Greto, Silvia Scoccianti, Monica Mangoni, Pierluigi Bonomo, Icro Meattini, L. Marrazzo, L. Paoletti and Massimiliano Fambrini and has published in prestigious journals such as Journal of Clinical Oncology, Radiotherapy and Oncology and Frontiers in Oncology.

In The Last Decade

Sara Lucidi

13 papers receiving 349 citations

Hit Papers

Accelerated Partial-Breast Irradiation Compared With Whol... 2020 2026 2022 2024 2020 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial
    2020 238 citations Icro Meattini, L. Marrazzo et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Lucidi Italy 7 215 118 97 79 78 15 352
Simona Borghesi Italy 13 160 0.7× 129 1.1× 69 0.7× 194 2.5× 77 1.0× 38 423
Tse-Kuan Yu United States 9 208 1.0× 229 1.9× 61 0.6× 96 1.2× 60 0.8× 9 382
L. Mangel Hungary 10 201 0.9× 63 0.5× 135 1.4× 74 0.9× 95 1.2× 18 342
Anke Keller Germany 12 325 1.5× 112 0.9× 239 2.5× 139 1.8× 144 1.8× 19 499
Francisca Ong Netherlands 10 173 0.8× 111 0.9× 60 0.6× 68 0.9× 123 1.6× 15 372
Kristina Braaten United States 6 138 0.6× 68 0.6× 133 1.4× 121 1.5× 219 2.8× 10 415
Walter M. Sahijdak United States 11 164 0.8× 106 0.9× 152 1.6× 168 2.1× 90 1.2× 17 491
Heike Scheithauer Germany 13 130 0.6× 133 1.1× 107 1.1× 113 1.4× 34 0.4× 15 377
Andrew C. Neuschatz United States 6 282 1.3× 103 0.9× 93 1.0× 100 1.3× 209 2.7× 8 407
Kunal Saigal United States 9 142 0.7× 124 1.1× 60 0.6× 88 1.1× 59 0.8× 23 324

Countries citing papers authored by Sara Lucidi

Since Specialization
Citations

This map shows the geographic impact of Sara Lucidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Lucidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Lucidi more than expected).

Fields of papers citing papers by Sara Lucidi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Lucidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Lucidi. The network helps show where Sara Lucidi may publish in the future.

Co-authorship network of co-authors of Sara Lucidi

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Lucidi. A scholar is included among the top collaborators of Sara Lucidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Lucidi. Sara Lucidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Rose, Fiorenza De, Maria Carmen De Santis, Sara Lucidi, et al.. (2024). Dose constraints in breast cancer radiotherapy. A critical review. Radiotherapy and Oncology. 202. 110591–110591. 11 indexed citations
2.
3.
Detti, Beatrice, Sara Lucidi, Saverio Caini, et al.. (2023). Choline PET/CT in recurrent prostate cancer. Frontiers in Oncology. 13. 1079808–1079808. 1 indexed citations
4.
Becherini, Carlotta, Andrea Lancia, Sara Lucidi, et al.. (2023). Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review. Strahlentherapie und Onkologie. 199(12). 1173–1190. 24 indexed citations
5.
6.
Detti, Beatrice, Silvia Scoccianti, Sara Lucidi, et al.. (2022). Pleomorphic Xanthoastrocytoma: a single institution retrospective analysis and a review of the literature. La radiologia medica. 127(10). 1134–1141. 12 indexed citations
7.
Francolini, Giulio, Beatrice Detti, Vanessa Di Cataldo, et al.. (2022). Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719). La radiologia medica. 127(8). 912–918. 5 indexed citations
8.
9.
Francolini, Giulio, Mauro Loi, Viola Salvestrini, et al.. (2021). Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275). Clinical & Experimental Metastasis. 38(5). 451–458. 6 indexed citations
10.
Detti, Beatrice, Silvia Scoccianti, Maria Ausilia Teriaca, et al.. (2021). Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients. La radiologia medica. 126(9). 1249–1254. 26 indexed citations
11.
Detti, Beatrice, Silvia Scoccianti, Sara Lucidi, et al.. (2020). Regorafenib in glioblastoma recurrence: A case report. Cancer Treatment and Research Communications. 26. 100263–100263. 11 indexed citations
12.
Bonomo, Pierluigi, Sara Lucidi, Isacco Desideri, et al.. (2020). Re-irradiation for oligoprogression under Nivolumab in recurrent head and neck squamous cell carcinoma: A case report. Clinical and Translational Radiation Oncology. 23. 16–19. 4 indexed citations
13.
Meattini, Icro, L. Marrazzo, Calogero Saieva, et al.. (2020). Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial. Journal of Clinical Oncology. 38(35). 4175–4183. 238 indexed citations breakdown →
14.
Francolini, Giulio, Mauro Loi, Monica Mangoni, et al.. (2020). Preliminary results of a prospective assessment of androgen receptor splice variants in mCRPC patients undergoing androgen receptor targeted agents.. Journal of Clinical Oncology. 38(6_suppl). 246–246. 3 indexed citations
15.
Greto, Daniela, Calogero Saieva, Mauro Loi, et al.. (2019). Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma. American Journal of Clinical Oncology. 42(10). 749–754. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simona Borghesi Breakdown of academic impact, for papers by Tse-Kuan Yu Breakdown of academic impact, for papers by L. Mangel Breakdown of academic impact, for papers by Anke Keller Breakdown of academic impact, for papers by Francisca Ong Breakdown of academic impact, for papers by Kristina Braaten Breakdown of academic impact, for papers by Walter M. Sahijdak Breakdown of academic impact, for papers by Heike Scheithauer Breakdown of academic impact, for papers by Andrew C. Neuschatz Breakdown of academic impact, for papers by Kunal Saigal
Rankless by CCL
2026